Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2012
04/12/2012WO2012045273A1 Moesin fragments and uses thereof
04/12/2012WO2012045157A1 Arih2 regulates dendritic cell activation and autoimmunity
04/12/2012WO2012045114A1 Agents and methods for treating hematologic conditions
04/12/2012WO2012024640A3 Mst1 as a prognostic biomarker and therapeutic target in human cancer
04/12/2012WO2012023623A3 Agent for treatment of hunter syndrome
04/12/2012WO2012023113A3 Designer osteogenic proteins
04/12/2012WO2012015996A3 Preservative free bimatoprost solutions
04/12/2012WO2012011144A3 Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
04/12/2012WO2012006599A3 Compstatin analogs for treatment of rhinosinusitis and nasal polyposis
04/12/2012WO2012006275A9 Treating non-hematopoietic cancer with interleukin 6
04/12/2012WO2012006083A3 Targeted receptor-mediated sirna
04/12/2012WO2012003370A3 Functional vascularization with biocompatible polysaccharide-based hydrogels
04/12/2012WO2011163452A9 Treating surface of the eye disorders
04/12/2012WO2011162831A9 Compositions and methods for treatment of thrombosis and prolonging survival of stored platelets
04/12/2012WO2011159881A3 Il-10 and methods of treating ocular and other diseases
04/12/2012WO2011159685A3 Inhibition of wdr5 interaction with its binding partners and therapeutic methods
04/12/2012WO2011156820A9 Compositions, methods and uses for treatment of type 1 diabetes
04/12/2012WO2011156686A3 Method for synthesizing a cyclic multivalent peptide using a thiol-mediated reaction
04/12/2012WO2011154403A3 Isolation of mesenchymal stem cells
04/12/2012WO2011153209A9 Cd36 inhibition to control obesity and insulin sensitivity
04/12/2012WO2011150082A9 Methods of utilizing the arrestin-2/stam-1 complex as a therapeutic target
04/12/2012WO2011126882A9 Therapeutic peptides and their derivatives and therapeutic uses thereof
04/12/2012WO2011043788A8 Daptomycin for multiple sclerosis
04/12/2012US20120090043 Targets for retrovirus associated diseases
04/12/2012US20120090042 Polypeptides Having Phytase Activity And Polynucleotides Encoding Same
04/12/2012US20120089084 Wound healing device
04/12/2012US20120089076 Method for treating inflammation
04/12/2012US20120088833 Modified amino acid for the inhibition of platelet aggregation
04/12/2012US20120088734 Cyclosporin Analogs
04/12/2012US20120088733 Novel use of antimicrobial peptides in regeneration of skin cells
04/12/2012US20120088732 Therapeutic composition comprising a botulinum neurotoxin
04/12/2012US20120088731 Method for treating parkinson's disease through regulating vdac1 protein
04/12/2012US20120088730 Use of angiotensin converting enzyme (ace) domain specific inhibitors to inhibit or enhance cytokine production and alter immune response
04/12/2012US20120088729 Non-glycosylated transferrin expressed in monocots
04/12/2012US20120088728 Use of c1 inhibitor for the prevention of ischemia-reperfusion injury
04/12/2012US20120088727 Rspondins as modulators of angiogenesis and vasculogenesis
04/12/2012US20120088726 Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical fromulations
04/12/2012US20120088725 5-cnac as oral delivery agent for parathyroid hormone fragments
04/12/2012US20120088724 Human Growth Hormone Formulations
04/12/2012US20120088723 Selective ep4 receptor agonistic substance for treatment of cancer
04/12/2012US20120088722 Compositions and methods for inhibition of mmp:mmp-substrate interactions
04/12/2012US20120088721 Cartilage Repair
04/12/2012US20120088720 Inhibitors of protein tyrosine phosphatases
04/12/2012US20120088718 Hcv-derived polypeptides and uses thereof
04/12/2012US20120088717 Method for treating fungal infection with antifungal bifunctional molecules
04/12/2012US20120088716 Polypeptide Protracting Tags
04/12/2012US20120088715 Mutated antithrombins, a process for preparing the same and their use as drugs
04/12/2012US20120088714 System for storage and subsequent handling of botulinum toxin
04/12/2012US20120088713 Tnf inhibitor formulation for use in implantable infusion devices
04/12/2012US20120088671 Anti-biofilm compositions and methods for using
04/12/2012US20120088297 Mycobacterial antigens expressed under low oxygen tension
04/12/2012US20120088270 Methods for producing antifungal bifunctional molecules for treating fungal infection
04/12/2012US20120088255 Her-2 binding antagonists
04/12/2012US20120088241 Bioreactive Agents
04/12/2012US20120087994 Systemic administration of nac as an adjunct in the treatment of bioterror exposures such as smallpox and use in combination with dhea for the treatment of smallpox
04/12/2012US20120087985 Small peptide sequences for stabilizing biomolecules
04/12/2012US20120087980 Stimulation of neuroregeneration by flavonoid glycosides
04/12/2012US20120087971 Contact drug delivery system
04/12/2012US20120087969 Mu-Conotoxin Peptides and Use Thereof as a Local Anesthetic
04/12/2012US20120087959 Nanodispersion of a drug and process for its preparation
04/12/2012US20120087956 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
04/12/2012US20120087955 Nanoparticulate megestrol formulations
04/12/2012US20120087950 Functionalized calcium phosphate artificial bone and joint compositions and methods of use and manufacture
04/12/2012US20120087947 Use of 2,5-dihydroxybenzene derivatives for treating dermatitis
04/12/2012US20120087935 Serine rich peptides having antioxidative stress properties
04/12/2012US20120087923 Antibodies to OPGL
04/12/2012US20120087918 Methods and compositions for inhibiting the growth of hematopoietic malignant cells
04/12/2012US20120087915 Use of inhibitors of bruton's tyrosine kinase (btk)
04/12/2012US20120087913 Induction of tumor hypoxia for cancer therapy
04/12/2012US20120087910 Sparc angiogenic domain and methods of use
04/12/2012US20120087909 Neutralizing monoclonal antibodies to respiratory syncytial virus
04/12/2012US20120087908 Factor vii composition
04/12/2012US20120087907 Prothrombic complex composition
04/12/2012US20120087906 Modified vitamin k-dependent polypeptides
04/12/2012US20120087905 Treatment of diseases related to hyperactivity of the complement system
04/12/2012US20120087904 Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Skin Cancer
04/12/2012US20120087898 Compositions comprising female germline stem cells and methods of use thereof
04/12/2012US20120087893 Combinations of a hcv inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent
04/12/2012US20120087892 Identification of dsg-3 as a biomarker for the detection of metastasis in lymph nodes
04/12/2012US20120087891 Reversible Gel-forming Compositions for Controlled Delivery of Bioactive Substances
04/12/2012US20120087890 IMMUNONANOTHERAPEUTICS THAT PROVIDE IgG HUMORAL RESPONSE WITHOUT T-CELL ANTIGEN
04/12/2012US20120087869 Methods for distributing agents to areas of brain
04/12/2012US20120087865 Treatment of ischemia
04/12/2012US20120087864 Method for diagnosing and/or evaluating retinal disease
04/12/2012US20120087859 Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties
04/12/2012DE102010047582A1 New receptor agonists exhibiting an activity e.g. diuresis, and influencing cyclic guanosine monophosphate, are natriuretic peptide receptors A and B binders, useful for prevention and/or therapy of disease e.g. pulmonary fibrosis
04/12/2012DE102010042359A1 Markersequenzen für Multiple Sklerose und deren Verwendung Marker sequences for multiple sclerosis and their use
04/12/2012CA2822024A1 Use of hyaluronan for promoting angiogenesis
04/12/2012CA2814030A1 Diagnostic and therapeutic uses of moesin fragments
04/12/2012CA2814029A1 Moesin fragments associated with immune thrombocytopenia
04/12/2012CA2814026A1 Moesin fragments associated with aplastic anemia
04/12/2012CA2814024A1 Moesin modulators and uses thereof
04/12/2012CA2814023A1 Moesin fragments and uses thereof
04/12/2012CA2813665A1 Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans
04/12/2012CA2813646A1 Multivalent synthetic compounds as antibiotic treatment
04/12/2012CA2813557A1 Method for activating helper t cell
04/12/2012CA2813337A1 Salts and polymorphs of sulfamide ns3 inhibitors
04/12/2012CA2812888A1 Factor ii and fibrinogen for treatment of haemostatic disorders
04/12/2012CA2812795A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases
04/12/2012CA2812543A1 Folate conjugates for treating inflammation of the eye
1 ... 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 ... 3163